Related Experiment Video
Updated: Aug 9, 2026

In vivo Measurement of the Mouse Pulmonary Endothelial Surface Layer
Published on: February 22, 2013
[Circulating adhesion molecules in patients with chronic obstructive pulmonary disease]
Ahmet Selim Yurdakul1, Nevin Taci Hoca, Filiz Cimen
1Atatürk Training and Research Hospital for Chest Disease and Thoracic Surgery, Ankara, Turkey. ahmetselimyurdakul@hotmail.com
This study found that Mac-1 levels in neutrophils decrease in Chronic Obstructive Pulmonary Disease (COPD) patients, while Mac-1 levels in lymphocytes decrease in smokers but increase with COPD development. Soluble intracellular adhesion molecule-1 (sICAM-1) and lymphocyte function associated antigen-1 (LFA-1) levels showed no significant changes.
Area of Science:
- Immunology
- Pulmonology
- Cell Biology
Context:
- The role of adhesion molecules in leukocyte migration during inflammation in Chronic Obstructive Pulmonary Disease (COPD) pathogenesis is debated.
- Investigating adhesion molecules like Mac-1, soluble intracellular adhesion molecule-1 (sICAM-1), and lymphocyte function associated antigen-1 (LFA-1) is crucial for understanding COPD.
- Leukocyte recruitment to inflamed tissues is a key process in inflammatory diseases, including COPD.
Purpose:
- To quantify and compare levels of sICAM-1, Mac-1, and LFA-1 in neutrophils and lymphocytes of stable COPD patients, smokers without COPD, and healthy non-smokers.
- To explore the relationship between these adhesion molecule levels and COPD severity.
- To elucidate the specific roles of Mac-1, sICAM-1, and LFA-1 in the context of smoking and COPD.
Summary:
- No significant differences in LFA-1 (in neutrophils and lymphocytes) and sICAM-1 were observed across COPD patients, smokers, and healthy controls.
- Mac-1 levels in peripheral blood neutrophils were significantly lower in COPD patients compared to smokers and healthy controls.
- Mac-1 levels in peripheral blood lymphocytes were higher in COPD patients compared to smokers, but not significantly different from healthy controls; however, lymphocyte Mac-1 decreased in smokers and increased with COPD development.
Impact:
- Findings suggest Mac-1 plays a differential role in neutrophils and lymphocytes during COPD development and smoking.
- The study indicates that sICAM-1 and LFA-1 may not be primary indicators of COPD or smoking status in this context.
- This research contributes to understanding the complex inflammatory mechanisms in COPD, potentially guiding future therapeutic strategies targeting adhesion molecules.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

